Initial experience with dynamic MR imaging in evaluation of normal bone marrow versus malignant bone marrow infiltrations in humans

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 241-250

  Bollow, Matthias ^a,b   Knauf, Wolfgang ^b   Korfel, Agnieszka ^b   Taupitz, Matthias ^a,b   Schilling, Andreas ^b   Wolf, Karl Jürgen ^b   Hamm, Bernd ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bone marrow, MR studies; Leukemia; MR, contrast enhancement; MR, phase imaging

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BONE MARROW METASTASIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FEMUR; HUMAN; IMAGE ANALYSIS; LUMBAR SPINE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 0031413276     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070138     Document Type: Article

References (50)

1. Rozman C, Herandez-Nieto L, Montserrat E, Brugues R. Prognostic significance of bone marrow patterns in chronic lymphocytic leukaemia. Br J Haematol 1981; 47:529-537.
2. Keating MJ, Kantarjan M, Talpaz M, et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukaemia. Blood 1989; 74:19-25.
3. Keatin MJ. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol 1990; 17(suppl):49-62.
4. Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. Bone marrow histologic pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984; 64:642-648.
5. Daffner RH, Lupetin AR, Dash N, et al. MRI in the detection of malignant infiltration of bone marrow. AJR 1986; 146:353-358.
6. Moore SG, Gooding CA, Brasch RC, et al. Bone marrow in children with acute lymphocytic leukemia: MR relaxation times. Radiology 1986; 160:237-240.
7. Dewes W, Ruhlmann J, Loos U, et al. MR tomography in lymphatic and leukaemic bone infiltrations. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1987; 147:654-661.
8. Thomsen C, Sørensen PG, Karle H, et al. Prolonged bone marrow T1-relaxation in acute leukaemia. In vivo tissue characterization by magnetic resonance imaging. Magn Reson Imaging 1987; 5:251-257.
9. Shields AF, Porter BA, Churchley S, et al. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol 1987; 5:225-230.
10. Renade SS, Trivedi PN, Bandivdekar AS. Value of correlation of cell type and T1 values to clinical magnetic resonance imaging of bone marrow. Physiol Chem Phys Med NMR 1988; 20: 159-164.
11. Vogler JB, Murphy WA. Bone marrow imaging. Radiology 1988; 168:679-693.
12. Döhner H, Gückel F, Knauf W, et al. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy. Br J Haematol 1989; 73:12-17.
13. Gückel F, Semmler W, Brix G, et al. Bone marrow changes in Hodgkin's disease. MR tomography and chemical shift imaging. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1989; 150:670-673.
14. Smith SR, Williams CE, Davies JM, Edwards RHT. Bone marrow disorders: characterization with quantitative MR imaging. Radiology 1989; 172:805-810.
15. Linden A, Zankovich R, Theissen P, et al. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology 1989; 173:335-339.
16. Tsoro-Tess JD, Balzarini L, Ceglia E, et al. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma. Eur J Radiol 1991; 12:81-90.
17. Kauczor HU, Bentz M, Bischoff H, et al. Bone marrow involvement in Hodgkin's disease: MR imaging and chemical shift imaging. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1993; 159:555-561.
18. Avrahami E, Tadmor R, Kaplinsky N. The role of T2-weighted gradient echo in MRI demonstration of spinal multiple myeloma. Spine 1993; 18:1812-1815.
19. McKinstry CS, Steiner RE, Young AT, et al. Bone marrow in leukemia and aplastic anemia: MR imaging before, during and after treatment. Radiology 1987; 162:701-707.
20. Thompson JA, Shields AF, Porter BA, et al. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to α-interferon. Leukemia 1987; 1: 315-316.
21. Silingardi V, Davolio-Marani S, Federico M, et al. Bone marrow infiltration in hairy cell leukemia after interferon therapy detected by magnetic resonance imaging. Eur J Cancer 1989; 25: 209-213.
22. Gückel F, Semmler W, Knauf W, et al. MRI quantification of infiltrative bone marrow changes and follow-up in patients with hairy cell leukaemia. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1990; 152:595-600.
23. Rahmouni A, Divine M, Mathieu D, et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR 1992; 160:1053-1057.
24. Moulopoulos LA, Dimopoulos MA, Alexanian R, et al. Multiple myeloma: MR patterns of response to treatment. Radiology 1994; 193:441-446.
25. Hanna SL, Fletcher BD, Fairclough DL, et al. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy. Skeletal Radiol 1991; 20:79-84.
26. Hosten N, Sander B, Schörner W, et al. MR imaging of bone marrow with gradient echo sequences: contrast conditions of phase-identical and opposed-phase gradient echo sequences. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1991; 154:614-620.
27. Lang P, Fritz R, Vahlensieck M, et al. Residual and reconverted hematopoeitic marrow in the distal femur. Spin-echo and opposed-phase gradient-echo MRI. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992; 156:89-95.
28. Stäbler A, Krimmel K, Seiderer M, et al. Differential diagnosis of benign and malignant vertebral compression fractures with MR imaging: value of antiphased long TR gradient-echo sequences, STIR sequences and Gd-DTPA. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992; 157:215-221.
29. Seiderer M, Wagner H, Stäbler A, Fink U. MRI of focal lesions of red bone marrow: optimization of acquisition parameters for GE and SE sequences. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1994; 160:453-458.
30. Hosten N, Schörner W, Neumann K, et al. Multiple myeloma: screening by Gd-DTPA enhanced opposed-phase gradient-echo MR imaging. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992; 157:53-58.
31. Hosten N, Neumann K, Zwicker C, et al. Diffuse demineralisation of the lumbar spine. MR imaging studies in osteoporosis and multiple myeloma. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1993; 159:264-268.
32. Binet JC, Latovsky D, Chandra P, et al. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Br J Haematol 1981; 48:365.
33. König H, Sieper J, Wolf KJ. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 1990; 176:473-477.
34. Reiser MF, Bongartz GP, Erlemann R, et al. Gadolinium-DTPA in rheumatoid arthritis and related diseases: first results with dynamic magnetic resonance imaging. Skeletal Radiol 1989; 18: 591-597.
35. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171:767-773.
36. Brunning RD, Bloomfield CDE, McKenna RW, Peterson L. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82:365-366.
37. Coller MD, Klatte EC, Baehner R, et al. Frequencies and patterns of bone marrow involvement in non-Hodgkin's lymphomas: observations on the value of bilateral biopsies. Am J Hematol 1977; 3:105-119.
38. Nyman R, Rehn S, Glimelius B, et al. Magnetic resonance imaging in diffuse malignant bone marrow diseases. Acta Radiol 1987; 28:199-203.
39. Jensen KE, Grube T, Thomsen C, et al. Prolonged bone marrow T1 relaxation in patients with polycythemia vera. Magn Reson Imaging 1988; 6:291-295.
40. Amano Y, Hayashi H, Kumazaki T. Gd-DTPA enhanced MRI of reactive hematopoietic regions in marrow. J Comput Assist Tomogr 1994; 18:214-217.
41. Lanir A, Aghai E, Simon JS, et al. MR imaging in myelofibrosis. J Comput Assist Tomogr 1986; 10:634-636.
42. Cristy M. Active bone marrow distribution as a function of age in humans. Phys Med Biol 1981; 26:389-400.
43. Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 1985; 14: 10-19.
44. Dooms GC, Fisher MR, Hricak H, et al. Bone marrow imaging magnetic resonance studies related to age and sex. Radiology 1985; 155:429-432.
45. Moore SG, Dawson KL. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 1990; 175:219-223.
46. Ricci C, Cova M, Kang YS, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990; 177:83-88.
47. Snyder WS, Cook MJ, Nasset ES, et al, eds. Report of the task group on reference man. New York: Pergamon Press, 1975.
48. Dixon WT. Simple proton spectroscopy imaging. Radiology 1984; 153:189-194.
49. Wismer GL, Rosen DR, Buxton R, et al. Chemical shift imaging of bone marrow: preliminary experience. Am J Radiol 1985; 145:1031-1037.
50. Cova M, Kang YS, Tsukamoto H, et al. Bone marrow perfusion evaluated with Gd-enhanced dynamic fast MR imaging in a dog model. Radiology 1991; 179:535-539.